BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25716060)

  • 1. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
    Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J
    Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process.
    Fuentealba C; Figuerola F; Estévez AM; Bastías JM; Muñoz O
    J Sci Food Agric; 2014 Jul; 94(9):1729-38. PubMed ID: 24243589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Pharmacokinetics of Enriched Secoisolariciresinol Diglucoside and Its Polymer in Rats.
    Yang X; Guo Y; Tse TJ; Purdy SK; Mustafa R; Shen J; Alcorn J; Reaney MJT
    J Nat Prod; 2021 Jun; 84(6):1816-1822. PubMed ID: 34043363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside.
    Roncaglia L; Amaretti A; Raimondi S; Leonardi A; Rossi M
    Appl Microbiol Biotechnol; 2011 Oct; 92(1):159-68. PubMed ID: 21614502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro.
    Hu C; Yuan YV; Kitts DD
    Food Chem Toxicol; 2007 Nov; 45(11):2219-27. PubMed ID: 17624649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats.
    Felmlee MA; Woo G; Simko E; Krol ES; Muir AD; Alcorn J
    Br J Nutr; 2009 Aug; 102(3):361-9. PubMed ID: 19216812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed.
    Rickard SE; Orcheson LJ; Seidl MM; Luyengi L; Fong HH; Thompson LU
    J Nutr; 1996 Aug; 126(8):2012-9. PubMed ID: 8759374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.
    Setchell KD; Brown NM; Zimmer-Nechemias L; Wolfe B; Jha P; Heubi JE
    Food Funct; 2014 Mar; 5(3):491-501. PubMed ID: 24429845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.
    Kitts DD; Yuan YV; Wijewickreme AN; Thompson LU
    Mol Cell Biochem; 1999 Dec; 202(1-2):91-100. PubMed ID: 10705999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flaxseed lignans added to milk or fed to cows on oxidative degradation of dairy beverages enriched with polyunsaturated fatty acids.
    Matumoto-Pintro PT; Petit HV; Giroux HJ; Côrtes C; Gagnon N; Britten M
    J Dairy Res; 2011 Feb; 78(1):111-7. PubMed ID: 21214967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1.
    Ren GY; Chen CY; Chen WG; Huang Y; Qin LQ; Chen LH
    Appl Physiol Nutr Metab; 2016 Dec; 41(12):1303-1310. PubMed ID: 27849354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.
    Adolphe JL; Whiting SJ; Juurlink BH; Thorpe LU; Alcorn J
    Br J Nutr; 2010 Apr; 103(7):929-38. PubMed ID: 20003621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial transformation of dietary lignans in gnotobiotic rats.
    Woting A; Clavel T; Loh G; Blaut M
    FEMS Microbiol Ecol; 2010 Jun; 72(3):507-14. PubMed ID: 20370826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside.
    Clavel T; Henderson G; Engst W; Doré J; Blaut M
    FEMS Microbiol Ecol; 2006 Mar; 55(3):471-8. PubMed ID: 16466386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of novel metabolites of flaxseed lignans in vitro and in vivo.
    Quartieri A; García-Villalba R; Amaretti A; Raimondi S; Leonardi A; Rossi M; Tomàs-Barberàn F
    Mol Nutr Food Res; 2016 Jul; 60(7):1590-601. PubMed ID: 26873880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone.
    Wang LQ; Meselhy MR; Li Y; Qin GW; Hattori M
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1606-10. PubMed ID: 11086885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia.
    Zhang W; Wang X; Liu Y; Tian H; Flickinger B; Empie MW; Sun SZ
    J Med Food; 2008 Jun; 11(2):207-14. PubMed ID: 18358071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical note: Quantification of lignans in the urine, milk, and plasma of flaxseed cake-fed dairy sheep.
    Zhuang CC; Feng X; Xu HY; Zhang L; Liu L; Zhang G; Zheng Z; Ma CM
    J Dairy Sci; 2021 Jan; 104(1):391-396. PubMed ID: 33189295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged administration of secoisolariciresinol diglycoside increases lignan excretion and alters lignan tissue distribution in adult male and female rats.
    Saarinen NM; Thompson LU
    Br J Nutr; 2010 Sep; 104(6):833-41. PubMed ID: 20388250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
    Zhang W; Wang X; Liu Y; Tian H; Flickinger B; Empie MW; Sun SZ
    Br J Nutr; 2008 Jun; 99(6):1301-9. PubMed ID: 18053310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.